Clinical outcome of Brazilian patients with non-small cell lung cancer in early stage harboring rare mutations in epidermal growth factor receptor

The common epidermal growth factor receptor (EGFR) mutations, such as the L858R point mutation in exon 21 and the in-frame deletional mutation in exon 19, have been definitively associated with response to EGFR-tyrosine kinase inhibitors (EGFR-TKI). However, the clinical outcome and response to trea...

Full description

Bibliographic Details

Published in:	Brazilian Journal of Medical and Biological Research
Main Authors:	J. Machado-Rugolo, C.M. Baldavira, T.G. Prieto, E.H.R. Olivieri, A.T. Fabro, C.A. Rainho, E.C. Castelli, P.E.M. Ribolla, A.M. Ab'Saber, T. Takagaki, M.A. Nagai, V.L. Capelozzi
Format:	Article
Language:	English
Published:	Associação Brasileira de Divulgação Científica 2023-01-01
Subjects:	Lung cancer Next generation sequencing Rare EGFR mutation Platinum-based chemotherapy Erlotinib
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2022000100687&tlng=en